Patient-Reported Quality of Life and Treatment Experiences Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept in Colombia: A Qualitative Study

Maria Adelaida Piedrahita, Wanderley Augusto Arias-Ortiz, Claudia Patricia Acosta Cadavid, Eduardo Cadena Galvis, Fernando Yaacov Peña · 2026

Read Patient-Reported Quality of Life and Treatment Experiences Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept in Colombia: A Qualitative Study by Maria Adelaida Piedrahita, Wanderley Augusto Arias-Ortiz, Claudia Patricia Acosta Cadavid, Eduardo Cadena Galvis, Fernando Yaacov Peña (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571611.txt.

Description

Piedrahita and four co-authors interviewed eye patients in Colombia in twenty twenty-six about life with a sight-stealing disease and its demanding treatment. The disease, wet age-related macular degeneration, damages central vision, and the standard care is a drug injected into the eye again and again.

Fourteen patients at a center in Medellín described their experience by phone. At first the injections frightened them, and fear of blindness hung over daily life. Over time, many came to link the treatment with hope, steadier sight, and kept independence. Family help, religious faith, and trust in their eye doctor carried them through. Reading, moving about, and social time all felt easier for some. Yet transport problems, reliance on others, and worry about getting the drug persisted. The authors urge care that treats feelings and logistics, not just the eye.

Catalog record

CREATORMaria Adelaida Piedrahita, Wanderley Augusto Arias-Ortiz, Claudia Patricia Acosta Cadavid, Eduardo Cadena Galvis, Fernando Yaacov Peña
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13571611

Browse the full library · About the Tower of Babel